Literature DB >> 29718310

Clinical Features and Outcomes of Children with Culture-Negative Septic Arthritis.

Evangelos Spyridakis1, Jeffrey S Gerber1,2,3, Emily Schriver1, Robert W Grundmeier4,3, Eric A Porsch3, Joseph W St Geme2,3, Kevin J Downes1,2,3.   

Abstract

BACKGROUND: Septic arthritis is a serious infection, but the results of blood and joint fluid cultures are often negative in children. We describe here the clinical features and management of culture-negative septic arthritis in children at our hospital and their outcomes.
METHODS: We performed a retrospective review of a cohort of children with septic arthritis who were hospitalized at Children's Hospital of Philadelphia between January 2002 and December 2014. Culture-negative septic arthritis was defined as a joint white blood cell count of >50000/μL with associated symptoms, a clinical diagnosis of septic arthritis, and a negative culture result. Children with pretreatment, an intensive case unit admission, Lyme arthritis, immunodeficiency, or surgical hardware were excluded. Treatment failure included a change in antibiotics, surgery, and/or reevaluation because of a lack of improvement/worsening.
RESULTS: We identified 157 children with septic arthritis. The patients with concurrent osteomyelitis (n = 28) had higher inflammatory marker levels at presentation, had a longer duration of symptoms (median, 4.5 vs 3 days, respectively; P < .001), and more often had bacteremia (46.4% vs 6.2%, respectively; P < .001). Among children with septic arthritis without associated osteomyelitis, 69% (89 of 129) had negative culture results. These children had lower C-reactive protein levels (median, 4.0 vs 7.3 mg/dL, respectively; P = .001) and erythrocyte sedimentation rates (median, 39 vs 51 mm/hour, respectively; P = .01) at admission and less often had foot/ankle involvement (P = .02). Among the children with culture-negative septic arthritis, the inpatient treatment failure rate was 9.1%, and treatment failure was more common in boys than in girls (17.1% vs 3.8%, respectively; P = .03). We found no association between treatment failure and empiric antibiotics or patient age. No outpatient treatment failures occurred during the 6-month follow-up period, although 17% of the children discharged with a peripherally inserted central catheter line experienced complications, including 3 with bacteremia.
CONCLUSIONS: The majority of septic arthritis infections at our institution were culture negative. Among patients with culture-negative infection, empiric antibiotics failed for 9% and necessitated a change in therapy. More sensitive diagnostic testing should be implemented to elucidate the causes of culture-negative septic arthritis in children.
© The Author(s) 2018. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antibiotics; osteoarticular infections; pediatrics; pyogenic arthritis

Mesh:

Substances:

Year:  2019        PMID: 29718310     DOI: 10.1093/jpids/piy034

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  3 in total

1.  Chronic seronegative spondyloarthropathy following acute Mycoplasma pneumoniae infection in a human leukocyte antigen B27-positive patient: a case report.

Authors:  Georgios Pilianidis; Ariti Tsinari; Dimitrios Pandis; Hara Tsolakidou; Nikolaos Petridis
Journal:  J Med Case Rep       Date:  2020-09-17

2.  Pilot study of a novel serum mRNA gene panel for diagnosis of acute septic arthritis.

Authors:  Blake J Schultz; Timothy Sweeney; Malcolm R DeBaun; Melissa Remmel; Uros Midic; Purvesh Khatri; Michael J Gardner
Journal:  World J Orthop       Date:  2019-12-18

3.  Use of Metagenomic Next-Generation Sequencing to Identify Pathogens in Pediatric Osteoarticular Infections.

Authors:  Nanda Ramchandar; Jessica Burns; Nicole G Coufal; Andrew Pennock; Benjamin Briggs; Rita Stinnett; John Bradley; John Arnold; George Y Liu; Maya Pring; Vidyadhar V Upasani; Kathleen Rickert; David Dimmock; Charles Chiu; Lauge Farnaes; Christopher Cannavino
Journal:  Open Forum Infect Dis       Date:  2021-07-17       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.